About Cerus Corporation
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.
Cerus Corporation (CERS) Stock Score & Signals
Cerus Corporation (CERS) trades on NASDAQ. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 50 out of 100.
2BB score and signals
Cerus Corporation’s current 2BB score is 50 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 61 | High |
| Momentum | 47 | Stable |
| Financial strength | 43 | Normal |
| Quality | 99 | Very Strong |
| Risk | 34 | Low |
Company facts
| Headquarters | Concord, California, United States |
| Founded | Sep 1991 |
| Employees | 268 |
| 52-week range | $1.38 – $3.47 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-01 | — | -0.0051 | — | $67.83M |
| 2026-10-29 | — | -0.0102 | — | $62.93M |
| 2026-07-30 | — | -0.0136 | — | $62.15M |
| 2026-04-30 | -0.01 | -0.0408 | $53.66M | $54.23M |